David L. Rimm MD, PhD

David L. Rimm MD, PhD, Professor of Pathology and of Medicine (Medical Oncology), Director of Pathology Tissue Services, Director of Translational Pathology, Yale School of Medicine, discusses the need for further research into tissue biomarkers in breast cancer.

Tissue biomarkers may help to determine which patients will respond to certain drugs.

Biologically, cancers are different. It is important to be able to determine how patients will respond to treatment.

Articles

David L. Rimm MD, PhD, from Yale School of Medicine, discusses the need for further research into tissue biomarkers in breast cancer.

David L. Rimm MD, PhD | Authors

Articles

The Need to Study Tissue Biomarkers